Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Andrew FeiginElizabeth E EvansTerrence L FisherJohn E LeonardErnest S SmithAlisha ReaderVikas MishraRichard ManberKimberly A WaltersLisa KowarskiDavid OakesEric SiemersKarl D KieburtzMaurice Zauderernull nullPublished in: Nature medicine (2022)